AI assistant
Sending…
ADC Therapeutics SA — Director's Dealing 2025
Dec 9, 2025
32916_dirs_2025-12-09_2060fac0-5bab-4ecd-af61-1a0ad691d562.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ADC Therapeutics SA (ADCT)
CIK: 0001771910
Period of Report: 2025-12-06
Reporting Person: Zaki Mohamed (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-06 | Common Shares | F | 41068 | $3.29 | Disposed | 421820 | Direct |
Footnotes
F1: Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.
More from ADC Therapeutics SA
Regulatory Filings
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 2
Report Publication Announcement
2026
May 4
Proxy Solicitation & Information Statement
2026
Apr 20
Regulatory Filings
2026
Mar 17
Capital/Financing Update
2026
Feb 23
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18